| Raymond E Faught Jr, MD | |
|
619 19th Street South, Birmingham, AL 35233 | |
| (205) 934-6600 | |
| Not Available |
| Full Name | Raymond E Faught Jr |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 52 Years |
| Location | 619 19th Street South, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497799134 | NPI | - | NPPES |
| P00236987 | Other | AL | RAILROAD MEDICARE |
| 00124767 | Other | MS | MISSISSPPI MEDICAID |
| C74435 | Other | AL | VIVA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 9314 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grady Memorial Hospital | Atlanta, GA | Hospital |
| Emory University Hospital | Atlanta, GA | Hospital |
| Saint Joseph's Hospital Of Atlanta, Inc | Atlanta, GA | Hospital |
| Emory University Hospital Midtown | Atlanta, GA | Hospital |
| Emory Decatur Hospital | Decatur, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emory Medical Care Foundation Inc | 4981501814 | 801 |
| The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
› Verified 4 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
› Verified 4 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond E Faught Jr, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Raymond E Faught Jr, MD 619 19th Street South, Birmingham, AL 35233 Ph: (205) 934-6600 |
News Archive
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
Australian scientists report that they may be on the brink of reversing type 2 diabetes after a genetic discovery. The finding centers on how a particular gene responds to high-fat diets by disrupting insulin production in the pancreas and triggering diabetes.
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
› Verified 4 days ago
Rayford W Thweatt, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Marla B Morgan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Robins J Newton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 400, Birmingham, AL 35205 Phone: 205-918-0507 Fax: 205-930-2716 | |
Mohamed Kazamel, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Dr. Rodney K Swillie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-971-3600 Fax: 844-772-0468 | |
Sandra L Frazier, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19t Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Michael Alonzo Lopez, M.D., PH.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1600 6th Ave S # Chb314, Birmingham, AL 35233 Phone: 205-996-7850 |